Skip to content

Acupuncture for Post-hemorrhoidectomy Pain Control

Acupuncture for Post-hemorrhoidectomy Pain Control With Acute Anti-inflammatory Effects: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07238504
Enrollment
100
Registered
2025-11-20
Start date
2026-03-31
Completion date
2027-04-30
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Hemorrhoidectomy, Hemorrhoid Pain

Brief summary

The goal of this clinical trial is to learn if acupuncture improves pain control after hemorrhoidectomy in patients with symptomatic hemorrhoids. It will also learn about the safety of using acupuncture in surgical patients. The main questions it aims to answer are: Does acupuncture lower the maximal pain intensity after hemorrhoidectomy? Does acupuncture reduce analgesics requirement, length of hospital stay and quality of recovery? Researchers will compare fully active acupuncture to a sham treatment (a look-alike procedure with minimum acupuncture stimulation) to see if active acupuncture works to improve pain control. Participants will: Receive acupuncture treatment for 7 times over first 5 days after surgery. Visit the clinic once 2 weeks after surgery for checkups and tests. Keep a diary of their symptoms and the number of times they take pain-killers.

Interventions

PROCEDUREAcupuncture

Acupuncture to 6 specific acupoints, 3 distant acupoints and electrical stimulation to 4 pairs of local acupoints.

Sponsors

School of Chinese Medicine, The University of Hong Kong
CollaboratorUNKNOWN
The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic grade III or IV hemorrhoids undergoing conventional hemorrhoidectomy

Exclusion criteria

1. Patients scheduled for stapled hemorrhoidopexy 2. Concomitant surgery other than conventional hemorrhoidectomy 3. Bleeding tendency, thrombocytopenia (platelet count \< 100 x 10\^9/L) 4. Immunocompromised status or use of chemotherapy 5. Active dermatitis 6. Patients with pacemaker or automated implantable cardioverter-defibrillator 7. Pregnant patients 8. Known allergy to opioids, local anaesthetic drugs, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDS) including cyclooxygenase-2 inhibitors 9. History of chronic pain (duration for 3 months or more) 10. Daily use of strong opioids (e.g. morphine, fentanyl, hydromorphone, methadone, oxycodone, or meperidine) 11. Alcohol or drug abuse 12. Psychiatric illness 13. Impaired renal function (preoperative serum creatinine level \> 120µmol/L) 14. Recent acupuncture treatment for other medical conditions

Design outcomes

Primary

MeasureTime frameDescription
Maximal pain intensityPost-operative day 1Numeric rating scale (minimum at 0 means 'no pain', maximum at 10 means 'worst pain')

Secondary

MeasureTime frameDescription
Maximal and resting pain intensityPost-operative day 0, 2 to 7 and 14Numeric rating scale (minimum at 0 means 'no pain', maximum at 10 mean 'worst pain')
Dosage of analgesics requirementPost-operative 2 weeksDosage of paracetamol, tramadol and celecoxib tablets taken per day over the first post-operative 2 weeks
Length of hospital stayPost-operative day 1
Serum C-reactive protein levelPost-operative day 0 and 1
Adverse effectPost-operative 2 weeksEffect from analgesics and acupuncture
Quality of recovery (QoR)Post-operative day 1QoR-15 questionnaire, which includes 15 questions scoring at a 10-point scale. Minimum at 0 means worst outcome and maximum at 10 means best outcome.
Functional recovery questionnairePost-operative 1 week (time to first bowel motion, time to first urination and time to return to work, counted from the day of operation)

Contacts

Primary ContactPak Chiu Wong
pwongpc@connect.hku.hk+852-70836168

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026